Sarepta Therapeutics Inc.

NASDAQ: SRPT · Real-Time Price · USD
21.66
1.36 (6.70%)
At close: Aug 15, 2025, 3:05 PM

Sarepta Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
235.24M -535.98M -703.49M -418.78M
Depreciation & Amortization
37.72M 44.4M 41.86M 38.02M
Stock-Based Compensation
184.3M 182.51M 233.02M 113.94M
Other Working Capital
-230.42M -97.54M -74.62M 13.96M
Other Non-Cash Items
53.56M 289.16M 142.73M -94M
Deferred Income Tax
n/a n/a n/a 15.81M
Change in Working Capital
-716.61M -481.09M -39.47M -98.17M
Operating Cash Flow
-205.79M -500.99M -325.35M -443.17M
Capital Expenditures
-136.96M -76.11M -30.82M -38.49M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-1.1B -2.05B -1.94B -29.99M
Sales Maturities Of Investments
2B 1.87B 923.22M 466M
Other Investing Acitivies
-10M 90.76M -2.43M 97.89M
Investing Cash Flow
755.56M -165.8M -1.05B 495.41M
Debt Repayment
-68K n/a 304.17M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
124.87M 125M -71.66M 13.04M
Financial Cash Flow
124.81M 125M 232.51M 561.57M
Net Cash Flow
674.58M -541.79M -1.14B 613.81M
Free Cash Flow
-342.74M -588.34M -356.17M -481.66M